PER 1.35% 7.5¢ percheron therapeutics limited

James Garner AKA JG, page-71

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    Apologies Sammy - you are right about consolidation!

    I only took a quick glance of charts…

    At the moment I take comfort the P2B trial is in the safe hands of Prof Voit.

    Let’s get the clinical results we want, then we have optionality re finance.

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.